Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
Profitability Metrics
Gross Margin
100.00%
Operating Margin
483.09%
Net Margin
621.49%
Efficiency Metrics
Revenue per Expense Ratio
-1,012,393.0
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
483.09%
Income Tax Rate
-16,789,500.0%
EPS
-0.2100000000
Balance Sheet Analysis
Current Ratio
0.00
Cash Ratio
4.81
Working Capital
$-3.07M
Debt to Equity
0.02
Debt to Assets
1.99%
Equity Ratio
83.60%
Cash Flow Analysis
Operating Cash Flow Ratio
-14,937.7%
Free Cash Flow Ratio
-14,937.7%
CapEx to Revenue
0.00%
Dividends Paid
$61.49M
Stock Buybacks
$30.07K
Total Shareholder Returns
$61.52M
Cash Position Change
-54.02%
Key Takeaways (2023 FY)
Revenue declined by 102.27320507898%, indicating potential market challenges
Increased dividend payments by 0.02%
Detailed Growth Metrics
Core Performance
Revenue
-102.27%
Net Income
-107.52%
EPS
-117.07%
Operating Income
16.21%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-10.60%
Operating Cash Flow
32,867.83%
Free Cash Flow
32,867.83%
Balance Sheet Health
Assets
-7.82%
Debt
-4.75%
Book Value per Share
-20.04%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
0.02%
Shares Outstanding
0.26%
Long Term Trends
3Y Revenue/Share
-102.52%
5Y Revenue/Share
-102.14%
3Y Dividend/Share
-0.59%
5Y Dividend/Share
-0.90%